Genes with high expression, high mutation frequency, and high MHC affinity were selected in CRC, STAD, UCEC, and SKCM for the proportion of samples where more than 5% of TMB were greater than 20 muts/MB. This evidence concerns the gene HLA-C and colorectal carcinoma.